1. Reversion of gene expression alterations in hearts of mice with chronic chagasic cardiomyopathy after transplantation of bone marrow cells
- Author
-
Regina Coeli dos Santos Goldenberg, Sanda Iacobas, Dumitru A. Iacobas, Milena Botelho Pereira Soares, Juliana Fraga Vasconcelos, Antonio Carlos Carvalho, Ricardo Lima, Leonardo L. Rocha, David C. Spray, Herbert B. Tanowitz, Ricardo Ribeiro dos Santos, Bruno Solano de Freitas Souza, and Michael P. Lisanti
- Subjects
Chagas Cardiomyopathy ,Male ,Galectin 3 ,Trypanosoma cruzi ,Cardiomyopathy ,Inflammation ,Biology ,Pathogenesis ,Mice ,Fibrosis ,von Willebrand Factor ,medicine ,Animals ,Molecular Biology ,Bone Marrow Transplantation ,Oligonucleotide Array Sequence Analysis ,Gene Expression Profiling ,Myocardium ,Cell Biology ,medicine.disease ,Mice, Inbred C57BL ,Transplantation ,Disease Models, Animal ,medicine.anatomical_structure ,Gene Expression Regulation ,Galectin-3 ,Heart failure ,Chronic Disease ,Immunology ,Female ,Syndecan-4 ,Bone marrow ,medicine.symptom ,Developmental Biology - Abstract
Chronic chagasic cardiomyopathy is a leading cause of heart failure in Latin American countries, being associated with intense inflammatory response and fibrosis. We have previously shown that bone marrow mononuclear cell (BMC) transplantation improves inflammation, fibrosis, and ventricular diameter in hearts of mice with chronic Chagas disease. Here we investigated the transcriptomic recovery induced by BMC therapy by comparing the heart transcriptomes of control, chagasic, and BMC transplanted mice. Out of the 9390 unique genes quantified in all samples, 1702 had their expression altered in chronic chagasic hearts compared to those of normal mice. Major categories of significantly upregulated genes were related to inflammation, fibrosis and immune responses, while genes involved in mitochondrion function were downregulated. When BMC-treated chagasic hearts were compared to infected mice, 96% of the alterations detected in infected hearts were restored to normal levels, although an additional 109 genes were altered by treatment. Transcriptomic recovery, a new measure that considers both resotrative and side effects of treatment, was remarkably high (84%). Immunofluorescence and morphometric analyses confirmed the effects of BMC therapy in the pattern of inflammatory-immune response and expression of adhesion molecules. In conclusion, by using large-scale gene profiling for unbiased assessment of therapeutic efficacy we demonstrate immunomodulatory effects of BMC therapy in chronic chagasic cardiomyopathy and identify potentially relevant factors involved in the pathogenesis of the disease that may provide new therapeutic targets.
- Published
- 2011
- Full Text
- View/download PDF